12902 Usf Magnolia DrTampa, FL 33612
Fax+1 813-972-7673
Overview of Dr. Kim
Dr. Richard Kim is a gastroenterologist in Tampa, FL and is affiliated with multiple hospitals in the area, including H. Lee Moffitt Cancer Center and Research Institute and James A. Haley Veterans' Hospital-Tampa. He received his medical degree from University of Miami Leonard M. Miller School of Medicine and has been in practice 17 years. Dr. Kim accepts several types of health insurance, listed below. He is one of 24 doctors at H. Lee Moffitt Cancer Center and Research Institute and one of 69 doctors at James A. Haley Veterans' Hospital-Tampa who specialize in Gastroenterology. He has more than 100 publications and over 500 citings.
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 2001 - 2003
University of Miami Leonard M. Miller School of MedicineClass of 2000
Certifications & Licensure
FL State Medical License 2010 - 2026
OH State Medical License 2006 - 2010
CT State Medical License 2003 - 2006
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma Start of enrollment: 2016 Jul 05
- Capecitabine and Lenvatinib With External Radiation in Rectal Adenocarcinoma Start of enrollment: 2016 Oct 14
- Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies Start of enrollment: 2020 Oct 12
- Join now to see all
Publications & Presentations
PubMed
- Practice Patterns and Survival Outcomes of Immunotherapy for Metastatic Colorectal Cancer.Shahla Bari, Marco Matejcic, Richard D Kim, Hao Xie, Ibrahim H Sahin
JAMA Network Open. 2025-03-03 - Safety of current treatments for advanced cholangiocarcinoma.Tiago Biachi de Castria, Richard D Kim
Expert Opinion on Drug Safety. 2025-03-01 - 1 citationsReal-world use of pemigatinib for the treatment of cholangiocarcinoma in the US.Kim Saverno, Kristin M Zimmerman Savill, Cherrishe Brown-Bickerstaff, Angele Kotomale, Michael Rodriguez
The Oncologist. 2025-01-17
Press Mentions
ctDNA Testing Shows Promise in Guiding CRC Treatment DecisionsJanuary 29th, 2025- ctDNA Testing Shows Promise for Influencing Colorectal Cancer TreatmentJanuary 27th, 2025
BCLC Staging and Treatment Algorithm: Does It Cover All?August 23rd, 2024
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
AvMed Health Open Access
BCBS Blue Card PPO
BCBS Florida BlueCare HMO
BCBS Florida NetworkBlue
BCBS Florida Preferred Patient Care PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPOCoventry Florida - Employer Group PPO
First Health PPO
Great West PPO
Health Net Oregon PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
